Literature DB >> 25900205

Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.

Haruhiko Nakamura1, Hisashi Saji2, Hideki Marushima2, Hiroyuki Kimura2, Rie Tagaya2, Noriaki Kurimoto2, Masahiro Hoshikawa3, Masayuki Takagi3.   

Abstract

PURPOSE: Maximum standardized uptake values (SUVmax) at the primary lesions of non-small-cell lung cancer in (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT), and the microscopic local extension of tumors were examined to develop reliable criteria to determine candidates for sublobar resection.
METHODS: We retrospectively analyzed 209 patients who underwent lobectomy, bilobectomy, or pneumonectomy with systematic lymph node dissection. Preoperative SUVmax at the primary lesion, microscopic lymphatic, venous, and pleural invasion in addition to lymph node metastases in the resected specimens were examined. Receiver operating characteristic analyses were used to predict an optimal cutoff for lymph node metastases.
RESULTS: With receiver operating characteristic analysis, the areas under the curve for SUVmax and tumor size were 0.693 and 0.545, respectively, suggesting SUVmax superiority for prediction of lymph node metastases with a cutoff of 2.9. When a tumor was ≤2.0 cm (n = 41, 19.6 %), the percentages of microscopic lymphatic invasion, venous invasion, pleural invasion, and lymph node metastases were 12.2, 7.3, 4.9, and 17.1 %, respectively. When SUVmax was <3.0 (n = 91, 43.5 %), these percentages were 15.4, 3.3, 7.7, and 8.8 %, showing that SUVmax could efficiently exclude nodal metastases in more cases than tumor size. The postoperative 5-year survival rate was 86.6 % in patients with SUVmax < 3.0 and 58.1 % in patients with SUVmax ≥ 3.0 (p < 0.001).
CONCLUSIONS: (18)F-FDG uptake value was more useful than tumor size for selecting patients with non-small-cell lung cancer suitable for intentional sublobar resection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25900205     DOI: 10.1245/s10434-015-4564-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.

Authors:  Ying Liu; Jongphil Kim; Yoganand Balagurunathan; Samuel Hawkins; Olya Stringfield; Matthew B Schabath; Qian Li; Fangyuan Qu; Shichang Liu; Alberto L Garcia; Zhaoxiang Ye; Robert J Gillies
Journal:  Med Phys       Date:  2018-04-29       Impact factor: 4.071

2.  Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy candidates.

Authors:  Shanyuan Zhang; Shaolei Li; Yuquan Pei; Miao Huang; Fangliang Lu; Qingfeng Zheng; Nan Li; Yue Yang
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

3.  Prognostic Significance of PD-L1 Expression and Standardized Uptake Values in the Primary Lesions of Stage IV Adenocarcinoma Lung Cancer.

Authors:  Bui Tien Cong; Pham Cam Phuong; Pham-Van Thai; Vu-Le Thuong; Nguyen Quang Hung; Dong-Thi Hang; Hoang Anh Tuan; Doan Minh Khuy; Pham-Van Tuyen; Nguyen Minh Duc
Journal:  Front Med (Lausanne)       Date:  2022-05-13

4.  Difference in Postsurgical Prognostic Factors between Lung Adenocarcinoma and Squamous Cell Carcinoma.

Authors:  Haruhiko Nakamura; Hiroki Sakai; Hiroyuki Kimura; Tomoyuki Miyazawa; Hideki Marushima; Hisashi Saji
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-10-02       Impact factor: 1.520

5.  Protein kinase C-iota-mediated glycolysis promotes non-small-cell lung cancer progression.

Authors:  Liu Liu; Bei Lei; Lihua Wang; Cheng Chang; Hao Yang; Jianjun Liu; Gang Huang; Wenhui Xie
Journal:  Onco Targets Ther       Date:  2019-07-18       Impact factor: 4.147

6.  Retention index of FDG-PET/CT SUVmax of the primary tumor in non-small cell lung cancer as a predictor of lymph node metastasis: a retrospective study.

Authors:  Toshinari Ema; Hideaki Kojima; Shinji Mizuno; Tatsuo Hirai; Mikako Oka; Hiroshi Neyatani; Kazuhito Funai; Norihiko Shiiya
Journal:  Eur J Hybrid Imaging       Date:  2022-09-27

Review 7.  18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer.

Authors:  Yusuke Takahashi; Shigeki Suzuki; Noriyuki Matsutani; Masafumi Kawamura
Journal:  Thorac Cancer       Date:  2019-01-21       Impact factor: 3.500

8.  Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.

Authors:  Tomoyuki Miyazawa; Kanji Otsubo; Hiroki Sakai; Hiroyuki Kimura; Motohiro Chosokabe; Kei Morikawa; Naoki Furuya; Hideki Marushima; Koji Kojima; Masamichi Mineshita; Junki Koike; Hisashi Saji
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.